HeartSciences IncHSCS
Price$3.89

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 31 Jul 2026
Market Price $3.89Price as of 1 Oct 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Discount rate (cost of equity) 11.7%
Volatility vs market (adjusted beta)1.50

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetHeartSciences IncHSCSHealth Care
Valuation
P/E—
P/S5,523.5×
P/B—
EV / Revenue6,314.7×
EV / EBITDA-0.8×
Profitability
Gross margin57.9%
Operating margin-89,939.6%
Net margin-227,024.2%
FCF margin-150,381.8%
Returns
ROE—
ROA-274.5%
ROIC—
Growth
Revenue growth (YoY)3.9%
5-yr fwd EPS growth—
Financial strength
Debt / Equity—
Current ratio0.14×
Altman Z-Score-40.8
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.